Xencor Inc (XNCR)
19.27
+0.04
(+0.21%)
USD |
NASDAQ |
Apr 26, 09:52
Xencor Cash from Investing (TTM): -111.06M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -111.06M |
September 30, 2023 | 116.61M |
June 30, 2023 | 74.41M |
March 31, 2023 | 0.178M |
December 31, 2022 | -119.72M |
September 30, 2022 | -136.41M |
June 30, 2022 | -178.39M |
March 31, 2022 | -156.06M |
December 31, 2021 | -46.25M |
September 30, 2021 | 24.67M |
June 30, 2021 | 12.96M |
March 31, 2021 | 125.68M |
December 31, 2020 | 100.19M |
September 30, 2020 | 37.14M |
June 30, 2020 | 109.76M |
March 31, 2020 | -52.08M |
December 31, 2019 | -50.97M |
September 30, 2019 | -59.83M |
June 30, 2019 | -76.03M |
March 31, 2019 | -163.77M |
December 31, 2018 | -164.77M |
Date | Value |
---|---|
September 30, 2018 | -162.69M |
June 30, 2018 | -163.62M |
March 31, 2018 | 35.98M |
December 31, 2017 | 31.86M |
September 30, 2017 | -81.97M |
June 30, 2017 | -214.56M |
March 31, 2017 | -215.38M |
December 31, 2016 | -214.27M |
September 30, 2016 | -151.07M |
June 30, 2016 | -16.47M |
March 31, 2016 | -126.39M |
December 31, 2015 | -185.11M |
September 30, 2015 | -144.00M |
June 30, 2015 | -151.51M |
March 31, 2015 | -50.89M |
December 31, 2014 | -2.283M |
September 30, 2014 | -1.707M |
June 30, 2014 | -1.518M |
March 31, 2014 | -1.178M |
December 31, 2013 | -1.278M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-178.39M
Minimum
Jun 2022
125.68M
Maximum
Mar 2021
-20.27M
Average
-46.25M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
Ionis Pharmaceuticals Inc | -214.13M |
Karyopharm Therapeutics Inc | 7.94M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |